Xevudy

(Note 2)

Sotrovimab (genetical recombination)

Approval Information

Brand NameXevudy

Generic NameSotrovimab (genetical recombination)

ApprovedSeptember 2021

Type(Note 2)

Review Reports

English Review Report

PDF · 462.64 KB

Japanese Review Report (1)

PDF · 1.44 MB

Japanese Review Report (2)

PDF · 108.86 KB

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.

← Back to Drug Database